Analyst Ratings: Changes for Safran, Renault, L'Oréal...
Target price increases dominate the session, from bioMérieux to SCOR and Ageas, while Forvia, Valeo and Kering see their targets cut. Several brokers also publish their position of the day on automotive, banking and luxury stocks.
Above their target: 9 stocks · SBF 120 stocks covered: 120
Stocks trading above their target: Eurofins Scientific (-15.6%) · Air France-KLM (-10.6%) · Icade (-10.5%) · Teleperformance (-10.0%) · Rémy Cointreau (-6.8%) · Métropole Télévision (-3.5%) · Dassault Systèmes (-2.7%) · Sodexo (-1.2%) · Imerys (-0.8%)
From €80 to €95 at bioMérieux: BofA Securities remains at “hold” and raises its target. 8 analysts had raised their targets over the past 10 days, the last move dating from November 5. Median target at €92.50, Target/price gap: +1%.
Renault switches camp at Jefferies: the rating moves from “hold” to “buy”, and the target from €30 to €34. The median target stands at €31.70, i.e. a Target/price gap of +7.3%. An analyst move was recorded on November 4.
Jefferies also takes on the automotive and biotech sectors with three downward adjustments, all accompanied by a “buy” rating. Forvia: target cut from €11.35 to €9.85; 4 analysts had lowered their targets over the past 10 days (last move on November 3), median at €11.75, Target/price gap: +30.9%. Valeo: from €17.85 to €13.80, median target unchanged at €13.80, Target/price gap: +21.6%. Inventiva: from €7.50 to €6.20, median at €8.50, Target/price gap: +151.1%.
At Safran, Bernstein shows an “outperform” rating and raises its target from €370 to €390. 3 analysts had nonetheless lowered their targets over the past 10 days (last move on November 9). Median at €345, Target/price gap: +8.7%.
On Viridien, Bernstein is at “outperform” with a target raised from €142 to €151, i.e. exactly the median. Target/price gap: +56.5%. 2 analysts had raised their targets and 1 had lowered it, the last move dating from November 5.
Four files for Goldman Sachs. Teleperformance: “neutral” rating, target from €68 to €72; the median stands at €62, Target/price gap: -10%. 1 analyst had raised and 3 had lowered their targets over the past 10 days. Pluxee: the rating moves from “sell” to “neutral”, the target from €11.60 to €12.20; median at €14.30, Target/price gap: +15.9%. 3 analysts had lowered their targets, the last on November 4. Interparfums: “buy” rating, target raised from €32 to €36.75; median at €33, Target/price gap: -8.7%.
Four financial stocks scrutinised by KBW. Ageas: from €68 to €86, “outperform” rating; median at €76.85, Target/price gap: -3.3%. SCOR: from €32 to €38, “outperform” rating; 5 analysts had raised their targets over the past 10 days (last move on November 5), median at €37, Target/price gap: +6.5%. Société Générale: from €75 to €76, “market perform” rating; median at €86.50, Target/price gap: +26.5%, with 2 target increases and 2 decreases over 10 days. Crédit Agricole S.A.: “underperform” rating, target cut from €18 to €16; median at €20.45, Target/price gap: +26.7%, after 2 target cuts, the last on November 9.
At €210 versus €233 previously: Kering sees SBG Securities move from “buy” to “hold” and cut its target. The median target stands at €230, Target/price gap: +19.5%. 2 analysts had lowered their targets, the last on November 9.
Dassault Systèmes: BofA Securities remains at “hold” and raises its target from €27 to €28. The median target stands at €24.50, Target/price gap: -2.7%. 2 analysts had raised their targets, the last on November 9.
Still at “sell”, BofA Securities raises its target from €12 to €14 on Air France-KLM. Median at €12.60, Target/price gap: -10.6%. 3 analysts had raised and 1 had lowered its target over the past 10 days.
At Ageas as elsewhere, the target is moving; at Solvay, Deutsche Bank remains at “hold” and lowers its target from €26 to €25, i.e. the median. Target/price gap: +1.6%. 2 analysts had lowered their targets, the last on November 6.
At €53 versus €51 previously, Barclays’ target on Bouygues rises. Median target at €55, Target/price gap: +25.7%.
Kepler Cheuvreux’s “hold” rating on L'Oréal comes with a target of €460, identical to the median. Target/price gap: +3.9%. 1 analyst had raised his target on November 9.
Berenberg is at “buy” on Lectra, target €26. Median at €24.50, Target/price gap: +29.1%.
For Guillemot, TP Icap Midcap shows a “Buy” rating and a target of €7. Median at €6.15, Target/price gap: +59.3%.
KBC Securities is at “buy” with a target of €37 on Lakefront Biotherapeutics; median at €24.50, Target/price gap: -16.7%. Same “buy” rating at Titan, target €60, median at €65, Target/price gap: +37%.
Finally, UCB: KBC Securities remains at “buy” and keeps its target at €290, i.e. the median. Target/price gap: -2.3%. 2 analysts had raised their targets, the last on November 5.
